-
Ascentage Has First U.S. Biotech IPO of 2025, Raising $126M to Bring Its Cancer Meds to the World
25 Jan 2025 00:45 GMT
… tyrosine kinases, enzymes that drive cancer growth. Tyrosine kinase inhibitors ( … available, such as the Novartis drugs Scemblix and Gleevec. But CML can become … Philadelphia chromosome-positive acute lymphocytic leukemia and gastrointestinal stromal tumor.
…
-
Evolution of Personalized Cancer Care With Molecular Profiling
21 Jan 2025 23:54 GMT
… (Gleevec), which offered a new treatment for patients with chronic myeloid leukemia … that cancer cells use to evade the immune system. These drugs have … :10.1056/NEJMoa052122
Gleevec FDA approval history. Drugs. Updated February 25 …
-
FTC report reveals PBMs inflate costs of specialty generic drugs
21 Jan 2025 23:24 GMT
… treatments for conditions such as cancer, multiple sclerosis and pulmonary … Oncology. Drugs such as abiraterone (generic Zytiga) and imatinib (generic Gleevec) saw … significant price markups, with some drugs marked up …
-
Insurance Company Where CEO Was Assassinated Jacking Up Cost of Cancer Drugs by "Thousands of Percent," Government Finds
16 Jan 2025 21:52 GMT
… of the leukemia medicine Gleevec, the prostate cancer drug abiraterone, and … acquisition costs for each drug annually."
Translation: … the expense of the cancer patients who needed them … for abiraterone, the prostate cancer drug, were shockingly high. …
-
UnitedHealth Charged Cancer Patients 5000%, Bombshell FTC Report Claims
16 Jan 2025 17:19 GMT
… of the study, two cancer drugs had the highest markup. … for comment.
Gleevec, the generic form of the leukemia drug Imatinib, was … form of the Abiraterone prostate cancer drug, that markup was 2299 … up two specialty generic cancer drugs by thousands of percent …
-
FTC says top three PBMs made $7.3 billion from marked up drug prices
16 Jan 2025 01:59 GMT
… of 51 specialty generic drugs comprising 882 National Drug Codes, which include the … to treat multiple sclerosis); Gleevec (used to treat leukemia); Sensipar (used to treat … than they reimburse pharmacies for drugs – on the drugs that were analyzed.
In …
-
FTC Says UnitedHealth, CVS, Cigna Make Billions Via PBMs On Specialty Drugs
15 Jan 2025 18:11 GMT
… essential medications used to treat cancer, HIV, and other critical … 51 specialty generic drugs, including critical medications such as Ampyra, Gleevec, Sensipar, and … Myfortic.
These drugs accounted for a significant …
-
Machine Learning Predicts Gleevec Nonadherence in Patients With GIST
15 Jan 2025 17:19 GMT
… in Cancer. The research also highlighted that predominant indicators for Gleevec nonadherence … were cognitive functioning, whether to perform therapeutic drug … TDM: whether to perform therapeutic drug monitoring on study.
“This study …
-
Pharmacy Benefits Managers Netted Extra $7.3B by Inflating Drug Prices: FTC
15 Jan 2025 16:46 GMT
… , steering more profitable specialty drugs toward those affiliated pharmacies and … of lifesaving drugs, including medications to treat heart disease and cancer,” FTC … to 2,435%) and cancer chemotherapies. Gleevec, the landmark leukemia drug, was marked up …
-
FTC Releases Second Interim Staff Report on Prescription Drug Middlemen
14 Jan 2025 23:18 GMT
… specialty generic drugs, including significant price markups by PBMs for cancer, HIV … to treat multiple sclerosis), Gleevec (used to treat leukemia), Sensipar (used to … their affiliated pharmacies—including drugs used to treat cancer, HIV, and other …